Bridgeway Capital Management, LLC Cara Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $235,804 - $470,196	141,200 New	141,200 $237,000
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $124,500 - $234,700	-10,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$17.57 - $23.95 $175,700 - $239,500	-10,000 Reduced 50.0%	10,000 $240,000
Q2 2018 Aug 14, 2018	SELL	$11.6 - $19.27 $406,000 - $674,450	-35,000 Reduced 63.64%	20,000 $383,000
Q3 2017 Nov 14, 2017	BUY	$12.6 - $16.34 $693,000 - $898,700	55,000	55,000 $753,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.